MAP
GMED icon

Madison Avenue Partners’s Globus Medical GMED Stock Holding History

Madison Avenue Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.9M Buy
935,216
+217,740
+30% +$18.5M 3.18% 11
2026
Q1 		$61.8M Sell
717,476
-1,907,275
-73% -$171M 2.69% 13
2025
Q4 		$229M Buy
2,624,751
+76,588
+3% +$5.81M 9.85% 3
2025
Q3 		$146M Buy
2,548,163
+836,015
+49% +$48.1M 8.71% 5
2025
Q2 		$101M Buy
+1,712,148
New +$111M 6.75% 7
2024
Q4 		– Sell
-1,137,050
Closed -$81.3M – 18
2024
Q3 		$81.3M Sell
1,137,050
-279,118
-20% -$19.7M 7.54% 5
2024
Q2 		$97M Buy
1,416,168
+712,892
+101% +$42.6M 12.25% 3
2024
Q1 		$37.7M Buy
+703,276
New +$37.8M 6.09% 7

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Madison Avenue Partners's GMED Position: Q2 2026 in Review

Madison Avenue Partners increased its Globus Medical (GMED) stake by 30% in Q2 2026, buying an estimated $18.5M and bringing the position to 935,216 shares worth $73.9M. The position accounts for 3.18% of the portfolio, ranked #11.

Madison Avenue Partners first reported a position in GMED in Q1 2024 and has held it in 8 quarters since. The position peaked at $229M in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Madison Avenue Partners held 935,216 shares of Globus Medical worth $73.9M as of Q2 2026.
  • Madison Avenue Partners bought 217,740 Globus Medical shares in Q2 2026, an estimated $18.5M.
  • Globus Medical made up 3.18% of Madison Avenue Partners's portfolio in Q2 2026, its #11 holding.
  • Madison Avenue Partners first reported a position in Globus Medical in Q1 2024 and has held it in 8 quarters since.
  • Madison Avenue Partners's Globus Medical position peaked at $229M in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Madison Avenue Partners's 13F filing for Q2 2026, filed 14 Aug 2026.